ALDOA and neoplasm: Tumor tissues were then subjected to H&E and Ki67 immunohistochemistry experiments, which showed that ALDOA K230/322R treatment significantly reduced the number of proliferating cells in tumors compared to ALDOA WT‐treated LCSCs (Figure S7b, Supporting Information).